This study will begin recruiting soon.
Assessment of a Wearable Ultrafiltration Device
Christopher McIntyreAbout This Study
This feasibility pilot study evaluates the safety and usability of a novel wearable Residual Ultrafiltration Device (RUF-D) in hemodialysis patients struggling with inadequate volume management. The intervention provides supplemental, slow fluid removal between standard hemodialysis sessions to mitigate the need for high ultrafiltration rates and reduce the risk of intradialytic hypotension and multi-organ ischemic injury. Investigators are enrolling 18 patients in a prospective, unblinded trial to compare volume status and clinical endpoints against baseline assessments. The primary objective is to determine if this simplified, wearable system can effectively offload fluid in patients who cannot tolerate conventional fluid removal within standard treatment time constraints.
Who Can Participate?
✓ Inclusion Criteria
- •At least one of the following:
- •Average per-session IDWG ≥ 4.0% of dry weight in the last month
- •Inability to consistently achieve dry weight with current HD
- •Need for additional HD treatments to achieve prescribed dry weight
- •HD sessions three times/week
- •Age ≥ 18 years
- •Dialyzing via central venous access
- •Willing and able to provide informed consent
✗ Exclusion Criteria
- •Active infections
- •Non-compliance to hemodialysis prescription/schedule